Status:
COMPLETED
Effects of 5-Methyltetrahydrofolate and Vitamin B12 Supplemetation on Red Cell Membrane in Children With Cystic Fibrosis
Lead Sponsor:
Universita di Verona
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
3-8 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether 5 - methyltetrahydrofolate and vitamin B12 supplementation can ameliorate cell plasma membrane features in pediatric patients with cystic fibrosis
Detailed Description
Cystic fibrosis (CF) is one of the most common fatal autosomal recessive disorders in the Caucasian population caused by mutations of gene for the cystic fibrosis transmembrane conductance regulator (...
Eligibility Criteria
Inclusion
- cystic fibrosis
Exclusion
- diabetes
- chronic infections of the airways
- regular antibiotics intake
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00730509
Start Date
April 1 2004
End Date
March 1 2006
Last Update
August 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Verona University
Verona, Italy, 37134